Wells Fargo & Company Kymera Therapeutics, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 14,452 shares of KYMR stock, worth $650,050. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,452

Previous 14,379 0.51%

Holding current value

$650,050

Previous $429,000 59.44%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$30.16 - $52.4 $2,201 - $3,825	73 Added 0.51%	14,452 $684,000
Q2 2024 Aug 13, 2024	BUY	$29.85 - $39.42 $39,431 - $52,073	1,321 Added 10.12%	14,379 $429,000
Q1 2024 May 10, 2024	BUY	$22.9 - $43.57 $51,937 - $98,816	2,268 Added 21.02%	13,058 $524,000
Q4 2023 Feb 09, 2024	SELL	$10.97 - $26.84 $279,548 - $683,963	-25,483 Reduced 70.25%	10,790 $274,000
Q3 2023 Nov 13, 2023	SELL	$13.9 - $23.88 $234,743 - $403,285	-16,888 Reduced 31.77%	36,273 $504,000
Q2 2023 Aug 15, 2023	BUY	$22.4 - $34.92 $243,801 - $380,069	10,884 Added 25.74%	53,161 $1.22 Million
Q1 2023 May 12, 2023	BUY	$24.84 - $38.75 $999,561 - $1.56 Million	40,240 Added 1975.45%	42,277 $1.25 Million
Q4 2022 Feb 13, 2023	SELL	$19.57 - $30.92 $28,767 - $45,452	-1,470 Reduced 41.92%	2,037 $50,000
Q3 2022 Nov 14, 2022	SELL	$20.91 - $34.27 $118,266 - $193,831	-5,656 Reduced 61.73%	3,507 $77,000
Q2 2022 Aug 12, 2022	SELL	$14.13 - $42.55 $131,465 - $395,885	-9,304 Reduced 50.38%	9,163 $180,000
Q1 2022 May 16, 2022	SELL	$35.3 - $64.68 $384,734 - $704,947	-10,899 Reduced 37.11%	18,467 $782,000
Q4 2021 Feb 14, 2022	SELL	$49.91 - $65.56 $305,249 - $400,964	-6,116 Reduced 17.24%	29,366 $1.87 Million
Q3 2021 Nov 15, 2021	BUY	$47.8 - $66.66 $1.63 Million - $2.27 Million	34,052 Added 2381.26%	35,482 $2.08 Million
Q2 2021 Aug 16, 2021	BUY	$31.08 - $51.95 $16,814 - $28,104	541 Added 60.85%	1,430 $69,000
Q1 2021 May 13, 2021	SELL	$35.64 - $85.46 $352,764 - $845,883	-9,898 Reduced 91.76%	889 $34,000
Q4 2020 Feb 09, 2021	BUY	$28.07 - $87.83 $302,791 - $947,422	10,787 New	10,787 $669,000

Others Institutions Holding KYMR

# of Institutions

184

Shares Held

64.4M

Call Options Held

50.6K

Put Options Held

81.7K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.46B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Kymera Therapeutics, Inc. Transaction History